USFDA nod to Zydus Lifesciences chronic heart failure drug Ruchika Sharma10 July 2024 5:20 PM ISTSacubitril and Valsartan combination is used to treat chronic heart failure in adults to help reduce the risk of death and hospitalization.
Zydus Lifesciences BP lowering drug receives USFDA tentative nod Ruchika Sharma4 July 2024 4:46 PM ISTAhmedabad: Zydus Lifesciences Limited has received tentative approval from the United States Food and Drug Administration (USFDA) to market...
Zydus Lifesciences bags USFDA tentative nod for Azilsartan Medoxomil and Chlorthalidone Tablets for hypertension Ruchika Sharma14 Jun 2024 4:02 PM ISTAhmedabad: Zydus Lifesciences Limited has announced that the Company has received tentative approval from the United States Food and Drug...
Zydus Lifesciences gets USFDA nod for asthma drug Theophylline ER Ruchika Sharma22 May 2024 3:45 PM ISTAhmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to market Theophylline...
Zydus Lifesciences appoints Shelina Parikh as Additional Director, Independent Director Ruchika Sharma18 May 2024 1:30 PM ISTAhmedabad: Zydus Lifesciences has approved the appointment of Shelina Parikh as an Additional Director as well as Independent Director of the...
Zydus Lifesciences arm, MSN Labs collaborate to license, supply cancer drug Cabozantinib in US Ruchika Sharma18 May 2024 12:27 PM ISTAhmedabad: Zydus Lifesciences Ltd., a global innovation driven healthcare company has announced that its wholly owned subsidiary, Zydus...
Zydus Lifesciences Dexamethasone Tablets bags USFDA okay Ruchika Sharma13 May 2024 11:22 AM ISTAhmedabad: Zydus Lifesciences Limited has announced that the Company has received final approval from the United States Food and Drug...
Zydus Lifesciences completes enrolment for EPICS III Phase 2b/3 trial evaluating Saroglitazar Mg for Primary Biliary Cholangitis Ruchika Sharma10 May 2024 11:56 AM ISTSaroglitazar Mg is a potent and selective peroxisome proliferator-activated receptor alpha and gamma dual agonist.
Zydus Lifesciences bags USFDA nod for Dapsone Gel for acne treatment Ruchika Sharma9 May 2024 2:52 PM ISTAhmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to market Dapsone...
Zydus Lifesciences bags USFDA nod for acne cream Tretinoin Ruchika Sharma27 April 2024 11:39 AM ISTAhmedabad: Zydus Lifesciences Limited has announced that the Company has received final approval from the United States Food and Drug...
USFDA issues 10 observations for Zydus Lifesciences Jarod facility Ruchika Sharma24 April 2024 4:01 PM ISTAhmedabad: Zydus Lifesciences has informed in a BSE filing that the US Food and Drug Administration (USFDA) has concluded an inspection with...
New Drug Application of Zydus Desidustat tablets by China Medical System Holdings accepted in China Ruchika Sharma24 April 2024 3:02 PM ISTDiscovered and developed by Zydus, Desidustat is being marketed by the group in India under the brand name Oxemia.
